Bone marrow transplantation for cancer - An update

Oncologist

Volumn 1, Issue 3, 1996, Pages 159-168

  Pavletic, Z Steven ^a,b   Armitage, James O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Allogeneic; Autologous; Bone marrow transplantation; Review; Standards; Stem cell; Utilization

Indexed keywords

EID: 0008886361     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.1-3-159     Document Type: Article

References (17)

1. Armitage JO. Bone marrow transplantation. N Engl J Med 1994;12:827-838.
2. Thomas ED. Nobel lecture, December 8, 1990. Bone marrow transplantation - past, present and future. Scand J Immunol 1994;39:339-345.
3. Horowitz MM. New IBMTR/ABMTR slides summarize current use and outcome of allogeneic and autologous transplants. IBMTR News Lett 1995;2:1-8.
4. Clift RA, Appelbaum FR, Thomas ED. Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1993;82:1954-1956.
5. McGlave P, Bartsch G, Anasetti C et al. Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program (NMDP). Blood 1993;81:543-550.
6. Fefer A, Radich J, Pavletic Z et al. Syngeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia in chronic phase: update of the original 14 Seattle patients, including PCR results. Blood 1994;84(suppl 1):252a.
7. Dexter TM, Chang J. New strategies for the treatment of chronic myeloid leukemia. Blood 1994;84:673-675.
8. Biggs JC, Horowitz MM, Gale RP et al. Bone marrow transplants cure persons with acute leukemia never achieving remission with chemotherapy. Blood 1992;80:1090-1093.
9. Clift RA, Buckner CD, Appelbaum FR et al. Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. J Clin Oncol 1992;10:1723-1729.
10. Clift RA, Buckner CD, Thomas ED et al. The treatment of acute non-Iymphoblastic leukemia by allogeneic marrow transplantation. Bone Marrow Transplant 1987;2:243-258.
11. Appelbaum FR, Fisher LD, Thomas ED et al. Chemotherapy versus marrow transplantation for adults with acute nonlymphocytic leukemia: a five year follow-up. Blood 1988;72:179-184.
12. Conde E, Iriondo A, Rayon C et al. Allogeneic bone marrow transplantation versus intensification chemotherapy for acute myelogenous leukemia in first remission: a prospective controlled trial. Br J Haematol 1988;68:219-226.
13. Cassileth PA, Lynch E, Hines JD et al. Varying intensity of postremission therapy in acute myeloid leukemia. Blood 1992;79:1924-1930.
14. Hewlett J, Kopecky KJ, Head D et al. A prospective evaluation of the roles of allogeneic marrow transplantation and low-dose monthly maintenance chemotherapy in the treatment of adult acute myelogenous leukemia (AML): a Southwest Oncology Group Study. Leukemia 1995;9:562-569.
15. Mayer RJ, Davis RB, Schiffer CA et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 1994;331:896-903.
16. Zittoun R, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 1995;332:217-223.
17. Anderson JE, Appelbaum FR, Fisher LD et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 1993;82:677-681.